ChinaNet Online Holdings, Inc. (CNET) Targets Growth with Digital Advertising Package for China’s SMEs – The QualityStocks Daily Blog for Micro-cap and Small-Cap Companies
ChinaNet Online Holdings, a B2B internet technology company delivering online-to-offline sales channel expansion services for small and medium-sized companies and entrepreneurial management and networking services for entrepreneurs in the People’s Republic of China, has announced they are laying out a new growth strategy that focusses on offering digital advertising services and a range of consumer analytics designed to add value for its small and medium-sized enterprise (SMEs) customers. CNET also continues to build on its analytics product suite which makes it possible to serve larger digital advertising clients in the People’s Republic of China through 2016.
Mr. Val Kaplin, a marketing executive based in China, noted, “China outspends every other country in the Asia Pacific region on digital advertising, which in 2013 reached US$13.23 billion, or approximately 11% of worldwide ad spending. Banner ads remain the most popular type of ads, and constitute 30.2% of digital display ads. Keyword search ads are next at 28.5%, which is still behind the US share of 47.1%. Baidu and Taoabao are the largest online advertisers in China by revenue, reporting RMB22.25 billion and RMB17.22 billion respectively and together represent over half the entire market. The largest spenders on online advertising are Chinese insurance giant Pingan, followed by Volkswagen, P&G and Shanghai GM. The four top sectors for online display ads are transportation, online services, real estate and food & drink.”
George Chu, ChinaNet Online’s COO commented, “We are very excited about our new focus on digital advertising and our cooperation with Baidu. We are also in discussions with Taobao of Alibaba to provide “Micro-Sell 360″, which is one of our new product solutions geared towards precision marketing for clients.”
One offering from ChinaNet .
The product is a web-portal designed to assist small to medium sized franchisors connect with new franchisees, Internet advertising and marketing, brand management and cloud-based management tools.
28.com is the largest merchant marketplace for franchise opportunity seekers in China.
ChinaNet Online Holdings, Inc., a parent company of ChinaNet Online Media Group Ltd., incorporated in the BVI, is a digital business to business Internet technology company focusing on providing RMB sales channel expansion service for small and medium-sized enterprises and entrepreneurial management and networking service for entrepreneurs in China. By way of contractual arrangements with operating companies in the PRC, the company provides Internet advertising and other services for Chinese SMEs via its portals, 28.com,
, TV commercials and program production via China-Net TV.
The company also offers in-house LCD advertising on banking kiosks targeting Chinese banking clients.
For more information on the company, visit
This entry was posted in
Select A Month
Categories
Select A Category
Newsletter Signup
Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.
Rotate your device 90& to view site.Zenosense, Inc. (ZENO) Pursues Super-Bug Device Development – The QualityStocks Daily Blog for Micro-cap and Small-Cap Companies
Zenosense is focused on emerging technology. From the start, the healthcare technology company has sought to develop an operational Super-Bug or Methicillin-resistant Staphylococcus aureus (MRSA) detector for use in hospitals, clinical environments and other healthcare settings.
Last year, Zenosense outsourced the development of its device to The Sgenia Group, a well-known sensor developer. Sgenia intends to model the new device after the algal (water) sensor platform it developed and to use a solo, commercial “off-the-shelf” gas sensor to sample the air and continuously check for the airborne Volatile Organic Compounds signature emitted by MRSA/SA. The device development process is intended to be completed in three distinct phases:
The first phase will be to produce a prototype that leverages Sgenia’s technology and successfully detects MRSA/SA contamination. Significant engineering work will be needed to adjust and adapt existing sensor capabilities to the planned application. The modification of algorithms will also be required to conform to MRSA/SA bacteria analysis. All of these developments will most likely be protected as industrial secrets rather than patents.
The second phase will be to build prototypes as well as conduct lab tests with a minimum of 20 beta versions of the MRSA/SA detection device. Next, a pre-production design appropriate for hospital use will have to be delivered. A vital aspect of this phase will be authenticating the device and achieving accuracy and repeatability. Testing will include: addressing the contaminating influences of environmental conditions, like humidity, temperature and other gasses, as well as the interference from other
and achieving the standard and quality levels required for hospital use.
The third and final phase will be to obtain pertinent regulatory approvals in the United States and European Union and to produce a final product ready for mass production and marketing. Steps during this phase will include: final testing by an external and specialist labora preparing and pursuing appli remedying any problems det as well as preparing for mass production of the device, once all relevant tests and approvals are obtained.
The development of the Zenosense device started in December 2013. Months later, in late October 2014, Zenosense announced that major progress had been made in the development of its MRSA/SA detector. The prototype device successfully achieved a sensibility detection rate greater than 95% on cultured headspace in a sequence of tests over a two-week period in a clinical setting. The general development of the device technology, which will detect the MRSA Super-Bug, was also proceeding in line with the company’s expectations.
For more information, visit
Let us hear your thoughts:
This entry was posted in
Select A Month
Categories
Select A Category
Newsletter Signup
Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.
Rotate your device 90& to view site.One World Holdings, Inc. (OWOO) Announces October Launch of Tween Scene Collection in Thousands of Walmart Stores – The QualityStocks Daily Blog for Micro-cap and Small-Cap Companies
One World Holdings, through its wholly-owned subsidiary, the One World Doll Project, recently announced the next phase of expansion for its acclaimed brand of multicultural fashion and play dolls. The highly anticipated Prettie Girls!(TM) Tween Scene collection will arrive in approximately 3,000 Walmart (NYSE: WMT) stores across the United States in October, providing the company with an opportunity to continue building on the success of its four original Prettie Girls! dolls.
“Our vision in developing the Prettie Girls! Tween Scene collection was to provide young girls with dolls that represent their individual backgrounds, stories, styles, goals and inspirations,” Trent T. Daniel, founder of OWOO, stated in a news release. “It is an honor to launch this new line, which endeavors to reflect America’s children, at Walmart, where America shops.”
The new collection will consist of pre-teen versions of the company’s original dolls, including all four of the Prettie Girls! characters, in addition to the introduction of two new personalities representing additional cultures and backgrounds. In total, the company’s new line will include African-American, Hispanic, South Asian, African, Asian and Caucasian dolls.
The Prettie Girls! were originally launched in 2010 by Daniel and Stacey McBride-Irby, a former designer for toy giant Mattel(R) who is widely regarded for her role in creating Mattel’s first African-American dolls. Since 2010, OWOO has received orders from a collection of major retailers, including Amazon, Walmart and Toys”R”Us. This increased presence has helped the company post improved financial results in recent months. In April, OWOO announced a 532 percent increase in annual year-over-year revenue in 2014, and the company’s management team expects continued growth moving toward the holiday season.
“It has already been a big year for us and as we continue to expand the Prettie Girls! brand across the nation, we expect to see even more sales performance as the 2015 Christmas season draws closer,” stated Joanne Melton, chief executive officer of OWOO.
According to the Toy Association, the domestic toy industry accounted for over $18 billion in revenue in 2014, with $2.32 billion attributed to the doll category. Through the release of the Prettie Girls! Tween Scene collection later this year, OWOO will be in a strong position to continue expanding upon its current share of the thriving market. For prospective investors, this announcement could foreshadow an extremely promising holiday season later this year.
For more information, visit
Let us hear your thoughts:
This entry was posted in
Select A Month
Categories
Select A Category
Newsletter Signup
Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.
Rotate your device 90& to view site.Performance Health Technologies, Inc. (PFMH.OB) CEO Takes Time for Interview
– The QualityStocks Daily Blog for Micro-cap and Small-Cap Companies
Recently, we had a chance to sit down with Performance Health Technologies (PFMH.OB) CEO Robert Prunetti. Appointed as President and CEO of Performance on March 15th, 2006, Prunetti reengineered the company, launching new marketing and product development strategies and eventually taking the company public.
While a leader in the boardroom, Prunetti is also a standout citizen. In 2003, Prunetti was named citizen of the year by the Greater Mercer County, New Jersey Chamber of Commerce. One of the main reasons for this recognition was Prunetti’s hard work and dedication with the Mercer County Open Space Trust Fund, which protected literally thousands of acres of the state’s natural resources in the area’s pristine natural spaces.
Though confronted with a busy schedule, Prunetti took time to answer questions about Performance Health Technology and its premier product, the Core: Tx(R), which is designed to teach stroke victims how to rehabilitate themselves to make their lives, and the lives of their families, easier after enduring the physical difficulties engendered by a stroke.
QS: Please give a brief overview of the Core: Tx(R)?
Core:Tx(R) is a computer-based program that uses wireless motion-sensing technology designed for neuromuscular re-education, a technique used by rehabilitation therapists to restore normal movement in patients with orthopedic and neuromuscular impairments resulting from trauma, medical conditions and neurological conditions such as stroke and traumatic brain injury.
QS: Is Performance Health strictly an NJ Company?
While Performance Health Technologies is based in Trenton, N.J., distribution partners like Interactive Metronome, based in Chicago, are helping bring our technology to a large clinical population across the country.
QS: Are there any products by Performance we should be on the lookout for?
Future products will include internet enabled software and hardware systems that allow users even more flexibility with their exercise routines, whether rehabbing from an injury or condition, or building strength and coordination.
Recently, PHT signed an agreement with Minneapolis-based Logic Product Development. Under the agreement, Logic, a product development and manufacturing company, will improve the usability and design of the next-generation Core:Tx(R) rehabilitation device. The updated version will be significantly smaller and lighter, read movement in multiple directions, and have multi-use capabilities for a more complex exercise program.
The product will also be able to run on Bluetooth technology for greater accuracy and improved signal strength, enabling the Core:Tx(R) to account for a more peripheral movement. The device is scheduled to be ready for release, along with the next generation of Core:Tx (R) software, which is planned to be web-enabled to allow for remote access to the therapy. With this product, patients will be able to remain connected to their physical therapists via the Internet.
QS: Where do you see Performance Health going in the next decade?
The market for consumer-electronic-based therapeutic and well-being products is expected to grow by 20 percent per year, reaching about $4 billion worldwide by 2010. Performance Health Technologies, Inc. is currently leading the way in the development and marketing of innovative products that guide and monitor exercise and rehabilitation. We remain committed to constant innovation of our products through the convergence of clinical knowledge and cutting-edge technology. Markets such as general fitness, sports performance exercise, and corrective exercise are targets for our products.
Let us hear your thoughts:
This entry was posted in
Select A Month
Categories
Select A Category
Newsletter Signup
Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.
Rotate your device 90& to view site.Cytomedix, Inc. (CMXI) to Highlight FDA-Cleared AutoloGel System at Symposium on Advanced Wound Care Fall 2012 – The QualityStocks Daily Blog for Micro-cap and Small-Cap Companies
Cytomedix, a developer of advanced autologous adult stem cell technologies for wound and tissue repair, will display its AutoloGel(TM) System in three poster presentations at the upcoming Symposium on Advanced Wound Care Fall 2012 (Sept 12-14) at the Baltimore Convention Center.
Cytomedix will also host a booth at the symposium where attendees and clinicians can learn more how AutoloGel can produce autologous platelet rich plasma (PRP) gel for use in wound management. The system is the only PRP device cleared by the U.S. Food and Drug Administration (FDA) for this application.
Presenting AutoloGel at the SAWC Fall 2012 provides exposure to the medical community and demonstrates the value of the system for wound care management.
“SAWC Fall 2012 is the ideal venue to showcase our growing body of positive clinical data on AutoloGel as it is the premier educational wound care program and the largest annual gathering of wound care professionals in the U.S., with more than 1,000 physicians, podiatrists, nurses, therapists and researchers expected to attend,” Martin P. Rosendale, CEO of Cytomedix stated in the press release. “These poster presentations underscore the robust nature of AutoloGel to advance the speed and progress to healing in a variety of recalcitrant wounds in a number of healthcare settings.”
Cytomedix’s will present the following posters at the SAWC Fall 2012: Aged Spinal Cord Injury Veterans with Recalcitrant Pressure Ulcers Treated with Platelet-Rich Plasma G Healing Complex, Severe Diabetic and Ischemic Wounds in Japan Using Platelet-Rich Plasma G and Advancing Wound Healing Trajectory with Platelet Rich Plasma Gel in Stalled NPWT Wounds.
For more information visit:
Let us hear your thoughts below:
This entry was posted in
Select A Month
Categories
Select A Category
Newsletter Signup
Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.
Rotate your device 90& to view site.